Comparative transdermal permeation of drugs

  • Research type

    Research Study

  • Full title

    Comparative transdermal permeation of active compounds from a range of platform dosage forms using horizontal diffusion cell technology with human skin

  • IRAS ID

    258224

  • Contact name

    Steve Metcalf

  • Contact email

    smetcalf@nemaura.co.uk

  • Sponsor organisation

    Nemaura Pharma Ltd

  • Clinicaltrials.gov Identifier

    Not applicable, Not applicable

  • Duration of Study in the UK

    1 years, 0 months, 0 days

  • Research summary

    Nemaura Pharma propose to procure human skin samples from a suitably accredited tissue bank such as Tissue Solutions, Glasgow and use them in the comparative in-vitro assessment of permeation from different formulation platforms, using horizontal diffusion (Franz) cell technology.

  • REC name

    London - Chelsea Research Ethics Committee

  • REC reference

    18/LO/2236

  • Date of REC Opinion

    3 Jan 2019

  • REC opinion

    Favourable Opinion